These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26588356)

  • 1. Late Failing Heart Allografts: Pathology of Cardiac Allograft Vasculopathy and Association With Antibody-Mediated Rejection.
    Loupy A; Toquet C; Rouvier P; Beuscart T; Bories MC; Varnous S; Guillemain R; Pattier S; Suberbielle C; Leprince P; Lefaucheur C; Jouven X; Bruneval P; Duong Van Huyen JP
    Am J Transplant; 2016 Jan; 16(1):111-20. PubMed ID: 26588356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased macrophage density of cardiac allograft biopsies is associated with antibody-mediated rejection and alloantibodies to HLA antigens.
    Xu L; Collins J; Drachenberg C; Kukuruga D; Burke A
    Clin Transplant; 2014 May; 28(5):554-60. PubMed ID: 24580037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac allograft vasculopathy: a donor or recipient induced pathology?
    van den Hoogen P; Huibers MM; Sluijter JP; de Weger RA
    J Cardiovasc Transl Res; 2015 Mar; 8(2):106-16. PubMed ID: 25652948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Assessment of Microcirculation Injury in Formalin-Fixed Human Cardiac Allograft Biopsies With Antibody-Mediated Rejection.
    Afzali B; Chapman E; Racapé M; Adam B; Bruneval P; Gil F; Kim D; Hidalgo L; Campbell P; Sis B; Duong Van Huyen JP; Mengel M
    Am J Transplant; 2017 Feb; 17(2):496-505. PubMed ID: 27401781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.
    Clerkin KJ; Farr MA; Restaino SW; Zorn E; Latif F; Vasilescu ER; Marboe CC; Colombo PC; Mancini DM
    J Heart Lung Transplant; 2017 May; 36(5):540-545. PubMed ID: 27916323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation.
    Tran A; Fixler D; Huang R; Meza T; Lacelle C; Das BB
    J Heart Lung Transplant; 2016 Jan; 35(1):87-91. PubMed ID: 26422083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
    Asimacopoulos EP; Garbern JC; Gauvreau K; Blume ED; Daly KP; Singh TP
    Transplantation; 2020 Jan; 104(1):e31-e37. PubMed ID: 31568274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor-Specific Antibodies Are Produced Locally in Ectopic Lymphoid Structures in Cardiac Allografts.
    Huibers MM; Gareau AJ; Beerthuijzen JM; Siera-de Koning E; van Kuik J; Kamburova EG; Vink A; de Jonge N; Lee TD; Otten HG; de Weger RA
    Am J Transplant; 2017 Jan; 17(1):246-254. PubMed ID: 27428759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive cardiac allograft rejection surveillance: reliability and clinical value for prevention of heart failure.
    Dandel M; Hetzer R
    Heart Fail Rev; 2021 Mar; 26(2):319-336. PubMed ID: 32889634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary arteries from human cardiac allografts with chronic rejection contain oligoclonal T cells: persistence of identical clonally expanded TCR transcripts from the early post-transplantation period (endomyocardial biopsies) to chronic rejection (coronary arteries).
    Slachta CA; Jeevanandam V; Goldman B; Lin WL; Platsoucas CD
    J Immunol; 2000 Sep; 165(6):3469-83. PubMed ID: 10975868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late Cardiac Allograft Failure, Cardiac Allograft Vasculopathy, and Antibody-Mediated Rejection: Untangling Some Knots?
    Burke MM
    Am J Transplant; 2016 Jan; 16(1):9-10. PubMed ID: 26588596
    [No Abstract]   [Full Text] [Related]  

  • 12. Early aspirin use, allograft rejection, and cardiac allograft vasculopathy in heart transplantation.
    Bergmark BA; Zelniker TA; Kim M; Mehra MR; Stewart GC; Page DS; Woodcome EL; Givertz MM
    Clin Transplant; 2021 Oct; 35(10):e14424. PubMed ID: 34254366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graft.
    Koskinen P; Lemstrøm K; Mattila S; Häyry P; Nieminen MS
    Clin Transplant; 1996 Dec; 10(6 Pt 1):487-93. PubMed ID: 8996768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of Routine Antihuman/Leukocyte Antibody Monitoring: De Novo Donor Specific Antibodies Are Associated With Rejection and Allograft Vasculopathy After Heart Transplantation.
    Wong KL; Taner T; Smith BH; Kushwaha SS; Edwards BS; Gandhi MJ; Kremers WK; Daly RC; Pereira NL
    Circulation; 2017 Oct; 136(14):1350-1352. PubMed ID: 28972064
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic plasma exchange rapidly improves cardiac allograft function in patients with presumed antibody-mediated rejection.
    Singh N; Vanlandingham S; Halverson C; Marques MB; Tallaj J; Kirklin J; Adamski J
    J Clin Apher; 2014 Dec; 29(6):316-21. PubMed ID: 24891048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejection-results from a first-in-patient phase 1 trial.
    Eskandary F; Jilma B; Mühlbacher J; Wahrmann M; Regele H; Kozakowski N; Firbas C; Panicker S; Parry GC; Gilbert JC; Halloran PF; Böhmig GA
    Am J Transplant; 2018 Apr; 18(4):916-926. PubMed ID: 28980446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-mediated vascular rejection of kidney allografts: a population-based study.
    Lefaucheur C; Loupy A; Vernerey D; Duong-Van-Huyen JP; Suberbielle C; Anglicheau D; Vérine J; Beuscart T; Nochy D; Bruneval P; Charron D; Delahousse M; Empana JP; Hill GS; Glotz D; Legendre C; Jouven X
    Lancet; 2013 Jan; 381(9863):313-9. PubMed ID: 23182298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenetic mechanisms of cardiac allograft vasculopathy--impact of nitric oxide.
    Koglin J
    Z Kardiol; 2000; 89 Suppl 9():IX/24-7. PubMed ID: 11151787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantation.
    Luque S; Lúcia M; Melilli E; Lefaucheur C; Crespo M; Loupy A; Bernal-Casas D; Gomà M; Jarque M; Crespo E; Montero N; Manonelles A; Cruzado JM; Gil-Vernet S; Grinyó JM; Bestard O
    Am J Transplant; 2019 Feb; 19(2):368-380. PubMed ID: 30085394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
    Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
    Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.